Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | RA CAPITAL MANAGEMENT L.P. | 2,538,925 9.900% | 493,897 (+24.15%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | Blue Owl Capital Holdings LP | 1,530,401 6.000% | 198,099 (+14.87%) | Filing History |
| 2024-11-14 4:32 pm Unchanged | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | VIKING GLOBAL INVESTORS LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 09:45 am Sale | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | Deep Track Capital, LP | 0 0.000% | -1,815,854 (Position Closed) | Filing History |
| 2024-11-14 09:39 am Purchase | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | AVORO CAPITAL ADVISORS LLC | 2,222,222 8.700% | 2,222,222 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | BlackRock Inc. BLK | 1,753,347 6.800% | 0 (Unchanged) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | BlackRock Inc. BLK | 1,753,347 6.800% | 1,753,347 (New Position) | Filing History |
| 2024-06-03 8:53 pm Purchase | 2024-05-23 | 13G | Tourmaline Bio, Inc. TRML | RA CAPITAL MANAGEMENT L.P. | 2,045,028 8.000% | 2,045,028 (New Position) | Filing History |
| 2024-03-15 07:45 am Unchanged | 2024-01-29 | 13G | Tourmaline Bio, Inc. TRML | PFIZER INC PFE | 1,272,214 4.960% | 0 (Unchanged) | Filing History |
| 2024-02-14 9:08 pm Purchase | 2023-12-31 | 13G | Tourmaline Bio, Inc. TRML | Hydra LLC | 1,702,164 6.600% | 500,000 (+41.59%) | Filing History |
| 2024-02-14 8:51 pm Purchase | 2023-12-31 | 13G | Tourmaline Bio, Inc. TRML | Blue Owl Capital Holdings LP | 1,332,302 6.550% | 1,332,302 (New Position) | Filing History |
| 2024-02-14 5:04 pm Unchanged | 2023-12-31 | 13G | Tourmaline Bio, Inc. TRML | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:57 pm Purchase | 2023-12-31 | 13G | Tourmaline Bio, Inc. TRML | Citadel Advisors LLC | 2,265 0.000% | 2,265 (New Position) | Filing History |
| 2024-02-09 5:24 pm Unchanged | 2023-12-31 | 13G | Tourmaline Bio, Inc. TRML | Blackstone Holdings II L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-09 4:22 pm Purchase | 2024-01-29 | 13G | Tourmaline Bio, Inc. TRML | TCG Crossover GP I LLC | 1,477,593 5.900% | 1,477,593 (New Position) | Filing History |
| 2024-02-07 2:11 pm Purchase | 2023-12-31 | 13G | Tourmaline Bio, Inc. TRML | BML Investment Partners, L.P. | 245,500 1.000% | 245,500 (New Position) | Filing History |
| 2023-11-06 4:30 pm Purchase | 2023-10-25 | 13G | Tourmaline Bio, Inc. TRML | Hydra LLC | 1,202,164 5.900% | 1,202,164 (New Position) | Filing History |
| 2023-10-30 5:16 pm Purchase | 2023-10-19 | 13D | Tourmaline Bio, Inc. TRML | Longitude Capital Partners III LLC | 322,077 1.600% | 322,077 (New Position) | Filing History |
| 2023-10-30 4:15 pm Purchase | 2023-10-19 | 13D | Tourmaline Bio, Inc. TRML | Qiming U.S. Healthcare GP II LLC | 646,770 3.200% | 646,770 (New Position) | Filing History |
| 2023-10-27 4:02 pm Purchase | 2023-10-20 | 13G | Tourmaline Bio, Inc. TRML | Deep Track Capital, LP | 1,815,854 8.930% | 1,815,854 (New Position) | Filing History |